pncA Mutations in the Specimens from Extrapulmonary Tuberculosis
- PMID: 23101013
- PMCID: PMC3475457
- DOI: 10.4046/trd.2012.72.6.475
pncA Mutations in the Specimens from Extrapulmonary Tuberculosis
Abstract
Background: Pyrazinamide (PZA) is an effective antitubercular drug that becomes toxic to Mycobacterium tuberculosis when converted to pyrazinoic acid by pyrazinamidase (PZase), encoded by mycobacterial pncA. A strong association was noted between the loss of PZase activity and PZA resistance. The causative organisms in extrapulmonary tuberculosis are rarely cultured and isolated. To detect pncA mutations in specimens from extrapulmonary tuberculosis as confirmative diagnosis of mycobacterial infection and alternative susceptibility test to PZA.
Methods: Specimens were collected from clinically proven extrapulmonary tuberculosis. pncA was sequenced and compared with wild-type pncA.
Results: pncA from 30 specimens from 23 donors were successfully amplified (56.6% in specimens, 59% in donors). Six mutations in pncA were detected (20.0% in amplified specimens, 26.1% in specimen donors) at nucleotide positions of 169, 248 and 419. The mutation at position 169 results in substitution of aspartic acid for histidine, a possible allelic variation of M. bovis that have intrinsic PZA resistance. The mutation at position 248 changes proline into arginine and that at position 419, arginine into histidine.
Conclusion: DNA-based diagnosis using pncA may be simultaneously useful for the early diagnosis of mycobacterial infection and the rapid susceptibility to PZA in extrapulmonary tuberculosis. A potential implication of pncA allelic variation at 169 might be suggested as a rapid diagnostic test for M. bovis infection or Bacille Calmette-Guérin (BCG) reactivation.
Keywords: Amidohydrolases; Antitubercular Agents; Mycobacterium bovis; Pyrazinamide; Tuberculosis.
Figures


Similar articles
-
pncA mutations as a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis: spread of a monoresistant strain in Quebec, Canada.Antimicrob Agents Chemother. 2000 Mar;44(3):528-32. doi: 10.1128/AAC.44.3.528-532.2000. Antimicrob Agents Chemother. 2000. PMID: 10681313 Free PMC article.
-
Patterns of pncA mutations in drug-resistant Mycobacterium tuberculosis isolated from patients in South Korea.Int J Tuberc Lung Dis. 2012 Jan;16(1):98-103. doi: 10.5588/ijtld.10.0739. Int J Tuberc Lung Dis. 2012. PMID: 22236853
-
Estimation of pyrazinamidase activity using a cell-free In vitro synthesis of pnca and its association with pyrazinamide susceptibility in Mycobacterium tuberculosis.Int J Mycobacteriol. 2018 Jan-Mar;7(1):16-25. doi: 10.4103/ijmy.ijmy_187_17. Int J Mycobacteriol. 2018. PMID: 29516881
-
The paradox of pyrazinamide: an update on the molecular mechanisms of pyrazinamide resistance in Mycobacteria.J Commun Dis. 2006 Mar;38(3):288-98. J Commun Dis. 2006. PMID: 17373362 Review.
-
The curious characteristics of pyrazinamide: a review.Int J Tuberc Lung Dis. 2003 Jan;7(1):6-21. Int J Tuberc Lung Dis. 2003. PMID: 12701830 Review.
Cited by
-
Comparative Genetic Association Analysis of Human Genetic Susceptibility to Pulmonary and Lymph Node Tuberculosis.Genes (Basel). 2023 Jan 13;14(1):207. doi: 10.3390/genes14010207. Genes (Basel). 2023. PMID: 36672948 Free PMC article.
-
Clinical and laboratory observation of Bacillus Calmette-Guérin infections.Int J Clin Exp Med. 2015 Jun 15;8(6):10099-104. eCollection 2015. Int J Clin Exp Med. 2015. PMID: 26309707 Free PMC article.
References
-
- Bass JB, Jr, Farer LS, Hopewell PC, O'Brien R, Jacobs RF, Ruben F, et al. Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society and The Centers for Disease Control and Prevention. Am J Respir Crit Care Med. 1994;149:1359–1374. - PubMed
-
- Scorpio A, Zhang Y. Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus. Nat Med. 1996;2:662–667. - PubMed
-
- Hirano K, Takahashi M, Kazumi Y, Fukasawa Y, Abe C. Mutation in pncA is a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis. Tuber Lung Dis. 1997;78:117–122. - PubMed
-
- Shim TS, Kim YW, Chin JY, Lim CM, Lee SD, Koh Y, et al. Detection of pyrazinamide-resistant Mycobacterium tuberculosis by PCR-SSCP of pncA gene. Tuberc Respir Dis. 1998;45:1178–1187.
LinkOut - more resources
Full Text Sources
Molecular Biology Databases